enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Disruptive mood dysregulation disorder - Wikipedia

    en.wikipedia.org/wiki/Disruptive_mood...

    Interestingly, recent studies indicate that children diagnosed with DMDD are 12.5% more likely to be prescribed any psychoactive medication, and 7.9% more likely to be prescribed an antipsychotic medication than children diagnosed with bipolar disorder. [29] At this time, DMDD does not have a standardized treatment course as few treatment ...

  3. 19 drug approvals in 2024 that had 'big clinical impact ... - AOL

    www.aol.com/news/19-drug-approvals-2024-had...

    GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of conditions. These medications are “slated to make a big clinical impact."

  4. Tasimelteon - Wikipedia

    en.wikipedia.org/wiki/Tasimelteon

    Tasimelteon, sold under the brand name Hetlioz, is a medication approved by the U.S. Food and Drug Administration (FDA) [3] in January 2014, for the treatment of non-24-hour sleep–wake disorder (also called non-24, N24 and N24HSWD). [4]

  5. Serotonin–norepinephrine reuptake inhibitor - Wikipedia

    en.wikipedia.org/wiki/Serotonin–norepinephrine...

    However, differences in metabolism, renal function, and total percentage of body water and body fat can influence the pharmacokinetics of medications in youths as compared to adults. [95] Additionally, there is a risk of increased suicidality in pediatric populations for treatment of major depressive disorder, especially with venlafaxine. [94]

  6. Levomilnacipran - Wikipedia

    en.wikipedia.org/wiki/Levomilnacipran

    Levomilnacipran (brand name Fetzima) is an antidepressant which was approved in the United States in 2013 for the treatment of major depressive disorder (MDD) in adults. [5] It is the levorotatory enantiomer of milnacipran, and has similar effects and pharmacology, acting as a serotonin–norepinephrine reuptake inhibitor (SNRI). [8] [9]

  7. US FDA approves Italfarmaco's drug for Duchenne muscle ... - AOL

    www.aol.com/news/us-fda-approves-italfarmacos...

    The U.S. FDA has approved privately held Italfarmaco Group's drug to treat Duchenne muscular dystrophy (DMD), an inherited muscle-wasting disorder, the health regulator said on Thursday. The oral ...

  8. As a provider who is certified in addiction medicine and only prescribes buprenorphine and naltrexone — two other FDA-approved medications for opioid use disorder — O’Connor said a lot of ...

  9. Trifluoperazine - Wikipedia

    en.wikipedia.org/wiki/Trifluoperazine

    Trifluoperazine, marketed under the brand name Stelazine among others, is a typical antipsychotic primarily used to treat schizophrenia. [3] It may also be used short term in those with generalized anxiety disorder but is less preferred to benzodiazepines. [3]